• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于特定引物 PCR 片段的磁性捕获铜纳米簇用于无标记荧光检测-基因中的 T315I 单核苷酸变异。

Copper nanoclusters on specific-primer PCR fragments with magnetic capture for the label-free fluorescent sensing of the T315I single nucleotide variant in the - gene.

机构信息

School of Pharmacy, College of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan, Republic of China.

Division of Orthopedic Surgery, Department of Surgery, Zuoying Branch of Kaohsiung Armed Forces General Hospital, Kaohsiung, Taiwan, Republic of China.

出版信息

Analyst. 2022 Dec 5;147(24):5732-5738. doi: 10.1039/d2an01433e.

DOI:10.1039/d2an01433e
PMID:36394571
Abstract

In this study, a simple and facile procedure using the all or none formation of double-stranded DNA-templated copper nanoclusters on specific-primer PCR fragments was designed to fluorescently identify the T315I single nucleotide variant on the - gene. Chronic myeloid leukaemia (CML), a disease caused by the - fusion of tyrosine kinase, is well known for the T315I mutation that causes tyrosine kinase inhibitors (TKIs) to be resisted due to the alternative structure of the drug-binding site. Therefore, it is an important single nucleotide variant for clinical detection. In this study, only specific functional primers and the digestion of the wild genotype from the T315I mutation site with specific restriction enzymes were designed, and the different digested products could then be captured using magnetic beads. The final products would allow for fluorescent sensing the all or none formation of double-stranded DNA-templated copper nanoclusters for the detection of the T315I mutation. This study has been successfully applied for identifying wild and mutant homozygotes and the mutant/wild heterozygote of the T315I mutation. It is expected that this analytical system can serve as a tool for the clinical diagnosis of T315I mutations and be applied to real samples of CML patients in the future.

摘要

在这项研究中,设计了一种简单易行的方法,利用双链 DNA 模板化铜纳米簇在特定引物 PCR 片段上的全有或全无形成来荧光识别 - 基因上的 T315I 单核苷酸变异。慢性髓性白血病(CML)是一种由酪氨酸激酶融合引起的疾病,其 T315I 突变导致酪氨酸激酶抑制剂(TKI)产生耐药性,因为药物结合位点的结构发生了改变,因此,T315I 突变是临床检测的一个重要单核苷酸变异。在这项研究中,仅设计了特定功能的引物和从 T315I 突变位点用特定的限制酶对野生型进行消化,然后可以使用磁珠捕获不同的消化产物。最终产物允许用于荧光检测双链 DNA 模板化铜纳米簇的全有或全无形成,以检测 T315I 突变。这项研究已成功应用于识别 T315I 突变的野生型和突变型纯合子以及突变型/野生型杂合子。预计这个分析系统可以作为 T315I 突变的临床诊断工具,并在未来应用于 CML 患者的实际样本。

相似文献

1
Copper nanoclusters on specific-primer PCR fragments with magnetic capture for the label-free fluorescent sensing of the T315I single nucleotide variant in the - gene.基于特定引物 PCR 片段的磁性捕获铜纳米簇用于无标记荧光检测-基因中的 T315I 单核苷酸变异。
Analyst. 2022 Dec 5;147(24):5732-5738. doi: 10.1039/d2an01433e.
2
A new rapid and sensitive assay for detecting the T315I BCR-ABL kinase domain mutation in chronic myeloid leukaemia.一种用于检测慢性髓性白血病中 T315I BCR-ABL 激酶结构域突变的新型快速灵敏检测方法。
J Clin Pathol. 2008 Jul;61(7):863-5. doi: 10.1136/jcp.2008.056804.
3
A pyrosequencing-based test for detection and relative quantification of the BCR-ABL1 T315I point mutation.基于焦磷酸测序的 BCR-ABL1 T315I 点突变检测和相对定量的检测方法。
J Clin Pathol. 2011 Jul;64(7):618-25. doi: 10.1136/jcp.2011.089193. Epub 2011 Apr 12.
4
CDK4/CDK6 inhibition as a novel strategy to suppress the growth and survival of BCR-ABL1+ clones in TKI-resistant CML.CDK4/CDK6 抑制作为一种抑制 TKI 耐药 CML 中 BCR-ABL1+克隆生长和存活的新策略。
EBioMedicine. 2019 Dec;50:111-121. doi: 10.1016/j.ebiom.2019.11.004. Epub 2019 Nov 21.
5
Axitinib effectively inhibits BCR-ABL1(T315I) with a distinct binding conformation.阿昔替尼通过独特的结合构象有效抑制 BCR-ABL1(T315I)。
Nature. 2015 Mar 5;519(7541):102-5. doi: 10.1038/nature14119. Epub 2015 Feb 9.
6
The Clinical Significance of BCR-ABL1 Mutations in Patients With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Who Underwent Allogeneic Hematopoietic Cell Transplantation.费城染色体阳性慢性髓性白血病患者行异基因造血细胞移植后 BCR-ABL1 突变的临床意义。
Transplant Cell Ther. 2022 Jun;28(6):321.e1-321.e8. doi: 10.1016/j.jtct.2022.03.009. Epub 2022 Mar 13.
7
Prevalence of BCR-ABL T315I Mutation in Malaysian Patients with Imatinib-Resistant Chronic Myeloid Leukemia.马来西亚伊马替尼耐药慢性髓性白血病患者中BCR-ABL T315I突变的患病率
Asian Pac J Cancer Prev. 2018 Dec 25;19(12):3317-3320. doi: 10.31557/APJCP.2018.19.12.3317.
8
Analysis of mutations in the BCR-ABL1 kinase domain, using direct sequencing: detection of the T315I mutation in bone marrow CD34+ cells of a patient with chronic myelogenous leukemia 6 months prior to its emergence in peripheral blood.应用直接测序法分析 BCR-ABL1 激酶结构域的突变:在慢性髓性白血病患者外周血中出现 T315I 突变前 6 个月,即在骨髓 CD34+细胞中检测到该突变。
Mol Diagn Ther. 2012 Jun 1;16(3):163-6. doi: 10.2165/11632420-000000000-00000.
9
Anthelmintic niclosamide suppresses transcription of BCR-ABL fusion oncogene via disabling Sp1 and induces apoptosis in imatinib-resistant CML cells harboring T315I mutant.驱虫药尼氯硝唑通过使 Sp1 失活来抑制 BCR-ABL 融合癌基因的转录,并诱导携带 T315I 突变的耐伊马替尼 CML 细胞凋亡。
Cell Death Dis. 2018 Jan 22;9(2):68. doi: 10.1038/s41419-017-0075-7.
10
Detection of BCR-ABL1 kinase domain mutations causing imatinib resistance in chronic myelogenous leukemia.慢性髓性白血病中导致伊马替尼耐药的BCR-ABL1激酶结构域突变的检测
Methods Mol Biol. 2013;999:25-39. doi: 10.1007/978-1-62703-357-2_2.

引用本文的文献

1
Multiplex one-step direct asymmetric PCR of blood and dual-labelled probe-mediated melting curve for genotyping of MTHFR and MTRR polymorphisms.血液的多重一步法直接不对称PCR及双标记探针介导的熔解曲线用于MTHFR和MTRR基因多态性的基因分型
RSC Adv. 2025 Jan 2;15(1):75-82. doi: 10.1039/d4ra07286c.